RBR-73gfct尚未招募3 期
o inferiority Phase III clinical trial, randomized, multicentre, parallel and blind to evaluated the efficacy and safety of Maxsulid® (Cosmed) compared to Nisulid® (Aché) medicine in the treatment of postoperative pain of third molar extraction.
Brainfarma Indústria Química e Farmacêutica S.A.0 个研究点开始时间: 2019年2月12日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 —（—）
入选标准
- •Sign the Informed Consent approved by the Ethics Committee,age greater than or equal 18 years old, participants of both sexes, have a third molar removal dental surgery in the last few hours and have a pain assessment on the VAS scale at least 50 mm.
排除标准
- •Have used anti-inflammatories or analgesics of any nature in the last 48 hours; Have a history of peptic ulcer or gastrointestinal bleeding; Illness of any nature that contraindicates participation in the study; Is not able to understand and perform the pain assessments present in the study; Hypersensitivity or contraindication known to the medications or components of the medications studied; Pregnant or lactating women; Professionals and their relatives who are directly involved in the process during this study; Participation in another study in less than one year.
研究者
相似试验
尚未招募
3 期
Phase III clinical trial of superiority, randomized, multicentre, blind, parallel, to evaluate the efficacy and safety of Lisador® (Cosmed) compared to Novalgina® 500mg (Sanofi-Medley) in the treatment of postoperative pain in abdominal-pelvic videolaparoscopypostoperative pain in abdomino- pelvicC23.888.592.612RBR-287dkzBrainfarma Indústria Química e Farmacêutica S.A.
已完成
3 期
Phase III clinical trial to compare the efficacy and safety of pegylated granulocyte colony stimulating factor(Peg G-CSF) versus granulocyte colony stimulating factor (G-CSF) in nonmyeloid malignancies subjects.CTRI/2009/091/001016Wockhardt Limited108
尚未招募
3 期
3-weekly versus weekly cisplatin as chemoradiotehrapy for head and neck cancerCTRI/2012/10/003062Tata memorial Hospital Mumbai300
进行中（未招募）
1 期
A randomised controlled phase III trial comparing hyperthermia plus mitomycin to a second course of bacillus Calmette-Guerin or standard therapy in patients with recurrence of non-muscle invasive bladder cancer following induction or maintenance bacillus Calmette-Guerin therapy. - Hyperthermia plus mitomycin (HYMN)on muscle invasive bladder cancerMedDRA version: 9.1 Level: LLT Classification code 10005006 Term: Bladder cancer stage 0, with cancer in situMedDRA version: 9.1 Level: LLT Classification code 10005007 Term: Bladder cancer stage 0, without cancer in situMedDRA version: 9.1 Level: LLT Classification code 10005008 Term: Bladder cancer stage I, with cancer in situMedDRA version: 9.1 Level: LLT Classification code 10005009 Term: Bladder cancer stage I, without cancer in situEUCTR2008-005428-99-GBniversity College London104
招募中
1 期
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of two formulations of vaginal micronized progesterone.infertilityCTIS2024-513102-57-00Santiago Dexeus Font Fundacio Privada1,020